aluates Reports

$ 0.0

Automative

Global CAR-T Cell Immunotherapies for Cancer Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-4D14285

Global CAR T Cell Immunotherapies for Cancer Market Research Report 2023

BUY CHAPTERS

Global CAR-T Cell Immunotherapies for Cancer Market Research Report 2025

Code: QYRE-Auto-4D14285

Report

June 2025

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

PENN

Fosun Pharma

Celgene Corporation

Legend Biotech

Sheba

JW Therapeutics

Protheragen

EXUMA Biotechnology

CAR-T Cell Immunotherapies for Cancer Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

CAR-T Cell Immunotherapies for Cancer Market

The global market for CAR-T Cell Immunotherapies for Cancer was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for CAR-T Cell Immunotherapies for Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-T Cell Immunotherapies for Cancer.

The CAR-T Cell Immunotherapies for Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CAR-T Cell Immunotherapies for Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the CAR-T Cell Immunotherapies for Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of CAR-T Cell Immunotherapies for Cancer Market Report

Report Metric	Details
Report Name	CAR-T Cell Immunotherapies for Cancer Market
CAGR	5%
Segment by Type	CD19 BCMA EPCAM
Segment by Application	Hematological Cancer Solid Tumor Other Oncological Disorders
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	NOVARTIS, Penn, Fosun Pharma, Celgene Corporation, Legend Biotech, SHEBA, JW Therapeutics, Protheragen, EXUMA Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CAR-T Cell Immunotherapies for Cancer company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the CAR-T Cell Immunotherapies for Cancer Market report?

Ans: The main players in the CAR-T Cell Immunotherapies for Cancer Market are NOVARTIS, Penn, Fosun Pharma, Celgene Corporation, Legend Biotech, SHEBA, JW Therapeutics, Protheragen, EXUMA Biotechnology

What are the Application segmentation covered in the CAR-T Cell Immunotherapies for Cancer Market report?

Ans: The Applications covered in the CAR-T Cell Immunotherapies for Cancer Market report are Hematological Cancer, Solid Tumor, Other Oncological Disorders

What are the Type segmentation covered in the CAR-T Cell Immunotherapies for Cancer Market report?

Ans: The Types covered in the CAR-T Cell Immunotherapies for Cancer Market report are CD19, BCMA, EPCAM

Recommended Reports

CAR-T Cell Therapy

Cancer Immunotherapy

Targeted Cancer Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global CAR-T Cell Immunotherapies for Cancer Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 CD19

1.2.3 BCMA

1.2.4 EPCAM

1.3 Market by Application

1.3.1 Global CAR-T Cell Immunotherapies for Cancer Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hematological Cancer

1.3.3 Solid Tumor

1.3.4 Other Oncological Disorders

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global CAR-T Cell Immunotherapies for Cancer Market Perspective (2020-2031)

2.2 Global CAR-T Cell Immunotherapies for Cancer Growth Trends by Region

2.2.1 Global CAR-T Cell Immunotherapies for Cancer Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 CAR-T Cell Immunotherapies for Cancer Historic Market Size by Region (2020-2025)

2.2.3 CAR-T Cell Immunotherapies for Cancer Forecasted Market Size by Region (2026-2031)

2.3 CAR-T Cell Immunotherapies for Cancer Market Dynamics

2.3.1 CAR-T Cell Immunotherapies for Cancer Industry Trends

2.3.2 CAR-T Cell Immunotherapies for Cancer Market Drivers

2.3.3 CAR-T Cell Immunotherapies for Cancer Market Challenges

2.3.4 CAR-T Cell Immunotherapies for Cancer Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top CAR-T Cell Immunotherapies for Cancer Players by Revenue

3.1.1 Global Top CAR-T Cell Immunotherapies for Cancer Players by Revenue (2020-2025)

3.1.2 Global CAR-T Cell Immunotherapies for Cancer Revenue Market Share by Players (2020-2025)

3.2 Global CAR-T Cell Immunotherapies for Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by CAR-T Cell Immunotherapies for Cancer Revenue

3.4 Global CAR-T Cell Immunotherapies for Cancer Market Concentration Ratio

3.4.1 Global CAR-T Cell Immunotherapies for Cancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by CAR-T Cell Immunotherapies for Cancer Revenue in 2024

3.5 Global Key Players of CAR-T Cell Immunotherapies for Cancer Head office and Area Served

3.6 Global Key Players of CAR-T Cell Immunotherapies for Cancer, Product and Application

3.7 Global Key Players of CAR-T Cell Immunotherapies for Cancer, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 CAR-T Cell Immunotherapies for Cancer Breakdown Data by Type

4.1 Global CAR-T Cell Immunotherapies for Cancer Historic Market Size by Type (2020-2025)

4.2 Global CAR-T Cell Immunotherapies for Cancer Forecasted Market Size by Type (2026-2031)

5 CAR-T Cell Immunotherapies for Cancer Breakdown Data by Application

5.1 Global CAR-T Cell Immunotherapies for Cancer Historic Market Size by Application (2020-2025)

5.2 Global CAR-T Cell Immunotherapies for Cancer Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America CAR-T Cell Immunotherapies for Cancer Market Size (2020-2031)

6.2 North America CAR-T Cell Immunotherapies for Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America CAR-T Cell Immunotherapies for Cancer Market Size by Country (2020-2025)

6.4 North America CAR-T Cell Immunotherapies for Cancer Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe CAR-T Cell Immunotherapies for Cancer Market Size (2020-2031)

7.2 Europe CAR-T Cell Immunotherapies for Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe CAR-T Cell Immunotherapies for Cancer Market Size by Country (2020-2025)

7.4 Europe CAR-T Cell Immunotherapies for Cancer Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific CAR-T Cell Immunotherapies for Cancer Market Size (2020-2031)

8.2 Asia-Pacific CAR-T Cell Immunotherapies for Cancer Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific CAR-T Cell Immunotherapies for Cancer Market Size by Region (2020-2025)

8.4 Asia-Pacific CAR-T Cell Immunotherapies for Cancer Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America CAR-T Cell Immunotherapies for Cancer Market Size (2020-2031)

9.2 Latin America CAR-T Cell Immunotherapies for Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America CAR-T Cell Immunotherapies for Cancer Market Size by Country (2020-2025)

9.4 Latin America CAR-T Cell Immunotherapies for Cancer Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size (2020-2031)

10.2 Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size by Country (2020-2025)

10.4 Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 NOVARTIS

11.1.1 NOVARTIS Company Details

11.1.2 NOVARTIS Business Overview

11.1.3 NOVARTIS CAR-T Cell Immunotherapies for Cancer Introduction

11.1.4 NOVARTIS Revenue in CAR-T Cell Immunotherapies for Cancer Business (2020-2025)

11.1.5 NOVARTIS Recent Development

11.2 Penn

11.2.1 Penn Company Details

11.2.2 Penn Business Overview

11.2.3 Penn CAR-T Cell Immunotherapies for Cancer Introduction

11.2.4 Penn Revenue in CAR-T Cell Immunotherapies for Cancer Business (2020-2025)

11.2.5 Penn Recent Development

11.3 Fosun Pharma

11.3.1 Fosun Pharma Company Details

11.3.2 Fosun Pharma Business Overview

11.3.3 Fosun Pharma CAR-T Cell Immunotherapies for Cancer Introduction

11.3.4 Fosun Pharma Revenue in CAR-T Cell Immunotherapies for Cancer Business (2020-2025)

11.3.5 Fosun Pharma Recent Development

11.4 Celgene Corporation

11.4.1 Celgene Corporation Company Details

11.4.2 Celgene Corporation Business Overview

11.4.3 Celgene Corporation CAR-T Cell Immunotherapies for Cancer Introduction

11.4.4 Celgene Corporation Revenue in CAR-T Cell Immunotherapies for Cancer Business (2020-2025)

11.4.5 Celgene Corporation Recent Development

11.5 Legend Biotech

11.5.1 Legend Biotech Company Details

11.5.2 Legend Biotech Business Overview

11.5.3 Legend Biotech CAR-T Cell Immunotherapies for Cancer Introduction

11.5.4 Legend Biotech Revenue in CAR-T Cell Immunotherapies for Cancer Business (2020-2025)

11.5.5 Legend Biotech Recent Development

11.6 SHEBA

11.6.1 SHEBA Company Details

11.6.2 SHEBA Business Overview

11.6.3 SHEBA CAR-T Cell Immunotherapies for Cancer Introduction

11.6.4 SHEBA Revenue in CAR-T Cell Immunotherapies for Cancer Business (2020-2025)

11.6.5 SHEBA Recent Development

11.7 JW Therapeutics

11.7.1 JW Therapeutics Company Details

11.7.2 JW Therapeutics Business Overview

11.7.3 JW Therapeutics CAR-T Cell Immunotherapies for Cancer Introduction

11.7.4 JW Therapeutics Revenue in CAR-T Cell Immunotherapies for Cancer Business (2020-2025)

11.7.5 JW Therapeutics Recent Development

11.8 Protheragen

11.8.1 Protheragen Company Details

11.8.2 Protheragen Business Overview

11.8.3 Protheragen CAR-T Cell Immunotherapies for Cancer Introduction

11.8.4 Protheragen Revenue in CAR-T Cell Immunotherapies for Cancer Business (2020-2025)

11.8.5 Protheragen Recent Development

11.9 EXUMA Biotechnology

11.9.1 EXUMA Biotechnology Company Details

11.9.2 EXUMA Biotechnology Business Overview

11.9.3 EXUMA Biotechnology CAR-T Cell Immunotherapies for Cancer Introduction

11.9.4 EXUMA Biotechnology Revenue in CAR-T Cell Immunotherapies for Cancer Business (2020-2025)

11.9.5 EXUMA Biotechnology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Novartis

PENN

Fosun Pharma

Celgene Corporation

Legend Biotech

Sheba

JW Therapeutics

Protheragen

EXUMA Biotechnology

List of Tables

Table 1. Global CAR-T Cell Immunotherapies for Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of CD19

Table 3. Key Players of BCMA

Table 4. Key Players of EPCAM

Table 5. Global CAR-T Cell Immunotherapies for Cancer Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global CAR-T Cell Immunotherapies for Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global CAR-T Cell Immunotherapies for Cancer Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global CAR-T Cell Immunotherapies for Cancer Market Share by Region (2020-2025)

Table 9. Global CAR-T Cell Immunotherapies for Cancer Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global CAR-T Cell Immunotherapies for Cancer Market Share by Region (2026-2031)

Table 11. CAR-T Cell Immunotherapies for Cancer Market Trends

Table 12. CAR-T Cell Immunotherapies for Cancer Market Drivers

Table 13. CAR-T Cell Immunotherapies for Cancer Market Challenges

Table 14. CAR-T Cell Immunotherapies for Cancer Market Restraints

Table 15. Global CAR-T Cell Immunotherapies for Cancer Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global CAR-T Cell Immunotherapies for Cancer Market Share by Players (2020-2025)

Table 17. Global Top CAR-T Cell Immunotherapies for Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cell Immunotherapies for Cancer as of 2024)

Table 18. Ranking of Global Top CAR-T Cell Immunotherapies for Cancer Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by CAR-T Cell Immunotherapies for Cancer Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of CAR-T Cell Immunotherapies for Cancer, Headquarters and Area Served

Table 21. Global Key Players of CAR-T Cell Immunotherapies for Cancer, Product and Application

Table 22. Global Key Players of CAR-T Cell Immunotherapies for Cancer, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global CAR-T Cell Immunotherapies for Cancer Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global CAR-T Cell Immunotherapies for Cancer Revenue Market Share by Type (2020-2025)

Table 26. Global CAR-T Cell Immunotherapies for Cancer Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global CAR-T Cell Immunotherapies for Cancer Revenue Market Share by Type (2026-2031)

Table 28. Global CAR-T Cell Immunotherapies for Cancer Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global CAR-T Cell Immunotherapies for Cancer Revenue Market Share by Application (2020-2025)

Table 30. Global CAR-T Cell Immunotherapies for Cancer Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global CAR-T Cell Immunotherapies for Cancer Revenue Market Share by Application (2026-2031)

Table 32. North America CAR-T Cell Immunotherapies for Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America CAR-T Cell Immunotherapies for Cancer Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America CAR-T Cell Immunotherapies for Cancer Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe CAR-T Cell Immunotherapies for Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe CAR-T Cell Immunotherapies for Cancer Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe CAR-T Cell Immunotherapies for Cancer Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific CAR-T Cell Immunotherapies for Cancer Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific CAR-T Cell Immunotherapies for Cancer Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific CAR-T Cell Immunotherapies for Cancer Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America CAR-T Cell Immunotherapies for Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America CAR-T Cell Immunotherapies for Cancer Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America CAR-T Cell Immunotherapies for Cancer Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size by Country (2026-2031) & (US$ Million)

Table 47. NOVARTIS Company Details

Table 48. NOVARTIS Business Overview

Table 49. NOVARTIS CAR-T Cell Immunotherapies for Cancer Product

Table 50. NOVARTIS Revenue in CAR-T Cell Immunotherapies for Cancer Business (2020-2025) & (US$ Million)

Table 51. NOVARTIS Recent Development

Table 52. Penn Company Details

Table 53. Penn Business Overview

Table 54. Penn CAR-T Cell Immunotherapies for Cancer Product

Table 55. Penn Revenue in CAR-T Cell Immunotherapies for Cancer Business (2020-2025) & (US$ Million)

Table 56. Penn Recent Development

Table 57. Fosun Pharma Company Details

Table 58. Fosun Pharma Business Overview

Table 59. Fosun Pharma CAR-T Cell Immunotherapies for Cancer Product

Table 60. Fosun Pharma Revenue in CAR-T Cell Immunotherapies for Cancer Business (2020-2025) & (US$ Million)

Table 61. Fosun Pharma Recent Development

Table 62. Celgene Corporation Company Details

Table 63. Celgene Corporation Business Overview

Table 64. Celgene Corporation CAR-T Cell Immunotherapies for Cancer Product

Table 65. Celgene Corporation Revenue in CAR-T Cell Immunotherapies for Cancer Business (2020-2025) & (US$ Million)

Table 66. Celgene Corporation Recent Development

Table 67. Legend Biotech Company Details

Table 68. Legend Biotech Business Overview

Table 69. Legend Biotech CAR-T Cell Immunotherapies for Cancer Product

Table 70. Legend Biotech Revenue in CAR-T Cell Immunotherapies for Cancer Business (2020-2025) & (US$ Million)

Table 71. Legend Biotech Recent Development

Table 72. SHEBA Company Details

Table 73. SHEBA Business Overview

Table 74. SHEBA CAR-T Cell Immunotherapies for Cancer Product

Table 75. SHEBA Revenue in CAR-T Cell Immunotherapies for Cancer Business (2020-2025) & (US$ Million)

Table 76. SHEBA Recent Development

Table 77. JW Therapeutics Company Details

Table 78. JW Therapeutics Business Overview

Table 79. JW Therapeutics CAR-T Cell Immunotherapies for Cancer Product

Table 80. JW Therapeutics Revenue in CAR-T Cell Immunotherapies for Cancer Business (2020-2025) & (US$ Million)

Table 81. JW Therapeutics Recent Development

Table 82. Protheragen Company Details

Table 83. Protheragen Business Overview

Table 84. Protheragen CAR-T Cell Immunotherapies for Cancer Product

Table 85. Protheragen Revenue in CAR-T Cell Immunotherapies for Cancer Business (2020-2025) & (US$ Million)

Table 86. Protheragen Recent Development

Table 87. EXUMA Biotechnology Company Details

Table 88. EXUMA Biotechnology Business Overview

Table 89. EXUMA Biotechnology CAR-T Cell Immunotherapies for Cancer Product

Table 90. EXUMA Biotechnology Revenue in CAR-T Cell Immunotherapies for Cancer Business (2020-2025) & (US$ Million)

Table 91. EXUMA Biotechnology Recent Development

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

Table 95. Authors List of This Report

List of Figures

Figure 1. CAR-T Cell Immunotherapies for Cancer Picture

Figure 2. Global CAR-T Cell Immunotherapies for Cancer Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global CAR-T Cell Immunotherapies for Cancer Market Share by Type: 2024 VS 2031

Figure 4. CD19 Features

Figure 5. BCMA Features

Figure 6. EPCAM Features

Figure 7. Global CAR-T Cell Immunotherapies for Cancer Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global CAR-T Cell Immunotherapies for Cancer Market Share by Application: 2024 VS 2031

Figure 9. Hematological Cancer Case Studies

Figure 10. Solid Tumor Case Studies

Figure 11. Other Oncological Disorders Case Studies

Figure 12. CAR-T Cell Immunotherapies for Cancer Report Years Considered

Figure 13. Global CAR-T Cell Immunotherapies for Cancer Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global CAR-T Cell Immunotherapies for Cancer Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global CAR-T Cell Immunotherapies for Cancer Market Share by Region: 2024 VS 2031

Figure 16. Global CAR-T Cell Immunotherapies for Cancer Market Share by Players in 2024

Figure 17. Global Top CAR-T Cell Immunotherapies for Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cell Immunotherapies for Cancer as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by CAR-T Cell Immunotherapies for Cancer Revenue in 2024

Figure 19. North America CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America CAR-T Cell Immunotherapies for Cancer Market Share by Country (2020-2031)

Figure 21. United States CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe CAR-T Cell Immunotherapies for Cancer Market Share by Country (2020-2031)

Figure 25. Germany CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific CAR-T Cell Immunotherapies for Cancer Market Share by Region (2020-2031)

Figure 33. China CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America CAR-T Cell Immunotherapies for Cancer Market Share by Country (2020-2031)

Figure 41. Mexico CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa CAR-T Cell Immunotherapies for Cancer Market Share by Country (2020-2031)

Figure 45. Turkey CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE CAR-T Cell Immunotherapies for Cancer Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. NOVARTIS Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2020-2025)

Figure 49. Penn Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2020-2025)

Figure 50. Fosun Pharma Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2020-2025)

Figure 51. Celgene Corporation Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2020-2025)

Figure 52. Legend Biotech Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2020-2025)

Figure 53. SHEBA Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2020-2025)

Figure 54. JW Therapeutics Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2020-2025)

Figure 55. Protheragen Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2020-2025)

Figure 56. EXUMA Biotechnology Revenue Growth Rate in CAR-T Cell Immunotherapies for Cancer Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

CAR T Cell Therapy Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chimeric Antigen Receptor CAR T Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

CAR T Therapy in Haematological Malignancy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancers Immunotherapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Tumor Immunotherapy Market

T Cell Lymphoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Stem Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chimeric Antigen Receptor Cell Therapy Market Research Report 2024

Cell Therapy Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gamma Delta T Cell Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

TCR Based Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cutaneous Cell Lymphoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Advanced Renal Cell Carcinoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Thymus Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Next Generation Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cutaneous T Cell Lymphoma CTCL Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4H16852

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37K16619

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30U16301

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-2G16953

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions